Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ELET3.SA
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -10.93 1.57 1.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -85.62 12.62 87.75
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.22 45.73 46.77
Cash -9.56 7.80 8.63
Capex 61.74 -0.31 -0.82
Free Cash Flow 161.66 0.27 -0.10
Revenue -14.29 3.78 4.41
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 9.15 0.48 0.44
Operating Margin 957.25 0.36 -0.03
ROA -62.85 < 0.005 < 0.005
ROE -63.31 < 0.005 < 0.005
ROIC 15804.84 -0.08 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ELET3.SA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ELET3.SA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ELET3.SA is permitted for members.